MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: U.S.(United States)
Industry: MidWest
*Industry: Indiana
BioCritica
Parents
*Architects: Infectious Disease _ Bacteriology_Antibiotics
*Industry: Indiana
Architects: Sepsis
Venture Capital: Series A
Children
2011: eli-lilly-forms-jv-biocritica-to-focus-on-sepsis-drug-xigris
Amt: 25M Round: Series A (2011)
BioCritica is a startup biotechnology company focused on continued development of Xigris, a pharmaceutical product for the treatment of sever sepsis.
Indianapolis, Indiana
Industry: Drug Development Sub-Industry: N/A
Investor(s) Care Capital, NovaQuest Capital
Jumps
Eli Lilly and Company (NYSE: LLY)*